Prometrium Cost in New Hampshire (2026): Prices, Insurance, and Savings

What Prometrium Actually Costs in New Hampshire Right Now

The gap between Prometrium's sticker price and what New Hampshire residents actually pay is wide. Solvay (now AbbVie) sets the wholesale acquisition cost at roughly $180 per month for brand-name Prometrium 200 mg capsules. That number rarely reflects the out-of-pocket price.

Across New Hampshire retail pharmacies in 2026, the average cash-pay price for generic micronized progesterone 200 mg (30 capsules) sits near $45 per month. Prices fluctuate by pharmacy. A CVS in Manchester may charge $52, while an independent pharmacy in Concord might quote $38. GoodRx-style discount cards can shave an additional 10 to 20 percent off the cash price in some locations.

The FDA-approved labeling for Prometrium specifies its use for prevention of endometrial hyperplasia in postmenopausal women receiving conjugated estrogens, as well as for secondary amenorrhea 1. The PEPI trial (N=875) established that micronized progesterone 200 mg for 12 days per cycle effectively opposed estrogen-induced endometrial hyperplasia while producing a more favorable lipid profile than medroxyprogesterone acetate 2. That trial changed prescribing patterns. It is the reason many clinicians now reach for micronized progesterone over synthetic progestins.

For patients paying out of pocket, cost matters because HRT is a long-term commitment. A woman starting Prometrium at age 52 and continuing through age 57 will spend roughly $2,700 over five years at current New Hampshire cash-pay rates, or about $1,500 if she switches to compounded micronized progesterone.

New Hampshire Medicaid and Prometrium: What's Covered

New Hampshire Medicaid does not cover Prometrium for endometrial protection in the context of hormone replacement therapy. This exclusion affects an estimated 180,000 NH residents enrolled in Medicaid and Medicaid expansion programs.

The state's preferred drug list categorizes HRT-related progestins as non-preferred, and prior authorization requests for Prometrium in the HRT indication are routinely denied. Medroxyprogesterone acetate (Provera) is the preferred progestin on the NH Medicaid formulary because of its lower acquisition cost.

Patients who require micronized progesterone specifically, whether due to side effects from medroxyprogesterone or clinician preference based on the PEPI lipid data, have limited recourse through Medicaid. The Endocrine Society's 2015 clinical practice guideline on the treatment of menopausal symptoms recommends micronized progesterone as a first-line option 3, but state Medicaid formularies are not obligated to follow specialty society recommendations.

Options for NH Medicaid enrollees who want micronized progesterone include: filing a formal appeal with supporting clinical documentation, switching to a compounded formulation paid out of pocket ($25/month), or working with a patient assistance program. AbbVie's patient assistance program may cover Prometrium for patients below 200% of the federal poverty level, though Medicaid-enrolled patients are typically excluded from manufacturer programs.

Insurance Coverage Across New Hampshire Commercial Plans

Most large commercial insurers in New Hampshire, including Anthem, Cigna, Harvard Pilgrim, and Ambetter, cover generic micronized progesterone capsules on their formularies. Brand-name Prometrium often requires a higher copay tier or prior authorization.

A typical formulary placement looks like this: generic micronized progesterone sits on Tier 2 (preferred generic) with a $10 to $25 copay, while brand Prometrium lands on Tier 3 (non-preferred brand) with a $40 to $75 copay. Some high-deductible health plans require the patient to pay the full negotiated rate until the deductible is met, which can mean $45 to $90 per fill depending on the pharmacy benefit manager's contracted price.

The New Hampshire Insurance Department does not mandate coverage of specific HRT medications, so formulary placement varies by plan and employer. Patients switching plans during open enrollment should verify that micronized progesterone appears on the prospective plan's formulary before enrolling.

The Women's Health Initiative (WHI) follow-up data, published in JAMA in 2017, showed that estrogen-plus-progestin therapy had a complex risk-benefit profile that varied by patient age and time since menopause 4. Insurers increasingly distinguish between synthetic progestins and micronized progesterone when reviewing prior authorization requests. A 2021 Obstetrics & Gynecology review noted that micronized progesterone may carry a lower breast cancer risk than synthetic progestins 5, a finding that strengthens the clinical rationale for prior authorization appeals.

Compounded Micronized Progesterone in New Hampshire

Compounded micronized progesterone is legal in New Hampshire through licensed 503A pharmacies. These pharmacies operate under section 503A of the Federal Food, Drug, and Cosmetic Act, which permits patient-specific compounding based on a valid prescription.

The typical cost for compounded micronized progesterone capsules (200 mg, 30-count) from a New Hampshire 503A pharmacy runs approximately $25 per month. That is roughly 45% less than the retail cash price for the FDA-approved generic. Several compounding pharmacies in the state fill these prescriptions, including operations in Nashua, Portsmouth, and the Concord area.

Why the price difference? Compounding pharmacies purchase USP-grade micronized progesterone powder in bulk and encapsulate it on-site. They do not bear the regulatory costs of an FDA-approved New Drug Application, manufacturing facility inspections at NDA scale, or brand marketing. The trade-off is that compounded products do not undergo the same bioequivalence testing as FDA-approved generics.

The North American Menopause Society (NAMS) 2022 position statement acknowledges that compounded bioidentical hormones are widely used but emphasizes that FDA-approved formulations should be preferred when available 6. The American College of Obstetricians and Gynecologists (ACOG) takes a similar position, recommending FDA-approved products as first-line and noting that compounded hormones lack standardized labeling and pharmacovigilance reporting 7.

Patients considering compounded micronized progesterone should confirm that the pharmacy holds a current New Hampshire Board of Pharmacy compounding license and uses USP <795> and USP <797> standards as applicable. Asking for a certificate of analysis for the progesterone powder batch is reasonable.

Telehealth Access for Prometrium in New Hampshire

New Hampshire permits telehealth prescribing of Prometrium and generic micronized progesterone. No in-person visit is required for the initial prescription, provided the prescribing clinician conducts an adequate clinical evaluation via synchronous audio-video encounter.

The state's telehealth parity law (RSA 415-J) requires commercial insurers to cover telehealth services at the same rate as in-person visits. This means a telehealth consultation for HRT management should carry the same copay as an office visit under most New Hampshire commercial plans.

Several telehealth platforms, including HealthRX, prescribe micronized progesterone to New Hampshire residents. The process typically involves a medical questionnaire, a video consultation with a licensed clinician, review of recent lab work (FSH, estradiol, and a lipid panel are common baseline labs), and electronic prescribing to the patient's preferred pharmacy.

For patients in rural areas of New Hampshire, including Coos County and the Upper Valley region, telehealth eliminates the need to drive 60 or more miles to reach an HRT-experienced clinician. The 2020 Census reported that 37.8% of New Hampshire's population lives in rural areas, making telehealth access a practical necessity rather than a convenience.

Dr. JoAnn V. Pinkerton, former executive director of NAMS, has stated: "Telehealth has become an important tool for menopause care delivery, particularly in areas with limited access to menopause-trained providers" 6.

How to Get the Lowest Price on Prometrium in New Hampshire

The cheapest route to micronized progesterone in New Hampshire depends on insurance status, income, and willingness to use compounded products. Here is a straightforward ranking.

Compounded micronized progesterone (~$25/month): Lowest out-of-pocket cost. Requires a prescription sent to a licensed 503A compounding pharmacy. Not covered by insurance.

Generic micronized progesterone with insurance (~$10 to $25/month copay): Lowest cost for commercially insured patients whose plan places the generic on Tier 1 or Tier 2.

Generic micronized progesterone, cash pay with discount card (~$35 to $50/month): Use GoodRx, RxSaver, or a similar aggregator to compare prices across NH pharmacies. Costco and Walmart pharmacies in Nashua, Manchester, and Salem frequently rank among the lowest-priced.

AbbVie/Solvay savings card (variable): The manufacturer savings card for brand Prometrium can reduce copays for commercially insured patients. Typical savings bring the copay down to $25 to $35 per fill. The card is not valid for patients covered by government insurance (Medicaid, Medicare Part D, Tricare). Patients can verify eligibility and activate the card through AbbVie's patient portal.

Mail-order pharmacy (~$35 to $40/month for 90-day supply): Express Scripts, CVS Caremark, and OptumRx all offer 90-day fills of generic micronized progesterone. The per-month cost on a 90-day fill is typically 10 to 15% lower than a 30-day retail fill.

A 2019 analysis in the Journal of Managed Care & Specialty Pharmacy found that mail-order pharmacy use was associated with lower total out-of-pocket costs and higher medication adherence for chronic medications 8. For a daily medication like progesterone, adherence matters. Missing doses can lead to breakthrough bleeding and inadequate endometrial protection.

Clinical Context: Why Progesterone Matters for HRT

Micronized progesterone is not optional for women with an intact uterus who take systemic estrogen. Unopposed estrogen increases the risk of endometrial hyperplasia and endometrial cancer. The PEPI trial demonstrated that 200 mg micronized progesterone for 12 days per cycle reduced the incidence of hyperplasia to rates comparable to placebo (no estrogen), while medroxyprogesterone acetate also prevented hyperplasia but adversely affected HDL cholesterol 2.

The E3N cohort study (N=80,377 postmenopausal women in France) reported that estrogen combined with micronized progesterone was not associated with an increased risk of breast cancer over a mean follow-up of 8.1 years, while estrogen combined with synthetic progestins was associated with a significantly elevated risk (RR 1.69 to 95% CI 1.50 to 1.91) 9. That finding has influenced prescribing preferences, particularly among menopause specialists.

Standard dosing for endometrial protection is 200 mg orally at bedtime for 12 to 14 days per calendar month (cyclic regimen) or 100 mg nightly (continuous regimen). The bedtime dosing is deliberate: micronized progesterone has a mild sedative effect mediated by its metabolite allopregnanolone, a positive allosteric modulator of GABA-A receptors 10.

Dr. Nanette Santoro, professor of obstetrics and gynecology at the University of Colorado School of Medicine, has noted: "Micronized progesterone is preferred by many clinicians because of its more physiologic profile and the reassuring breast safety data from European cohorts" 6.

Brand vs. Generic vs. Compounded: A Direct Comparison

Three forms of micronized progesterone are available in New Hampshire. Each carries different cost, regulatory, and clinical considerations.

Brand Prometrium (AbbVie): FDA-approved. Bioequivalence established. Contains peanut oil as a suspension medium. List price ~$180/month. Available at all retail pharmacies. Covered by most commercial plans at Tier 3.

Generic micronized progesterone (multiple manufacturers): FDA-approved via ANDA pathway. Bioequivalence demonstrated against brand. Some generics use peanut oil; others use sunflower or other oils. Cash price ~$45/month in NH. Preferred by most insurance formularies at Tier 2.

Compounded micronized progesterone (503A pharmacy): Not FDA-approved. Quality depends on the compounding pharmacy's practices and oversight. Can be formulated without peanut oil for patients with peanut allergy. Cost ~$25/month. Not covered by insurance.

The peanut oil consideration is clinically relevant. Prometrium's labeling carries a contraindication for patients with known peanut allergy 1. While severe allergic reactions are rare, patients with documented peanut allergy should use a generic formulated without peanut oil or a compounded preparation using an alternative vehicle.

New Hampshire has 12 licensed compounding pharmacies that routinely prepare micronized progesterone capsules, according to the NH Board of Pharmacy's 2025 registry. Patients should confirm 503A licensure status before filling a prescription at any compounding pharmacy.